Literature DB >> 10205347

Energy expenditure during allogeneic and autologous bone marrow transplantation.

V Chamouard Cogoluenhes1, C Chambrier, M Michallet, B Gordiani, J Y Ranchere, D Combret, Y Lallemand, M Roldan, M Accominoti, I Philip, J F Latour, G Hulewitz, P Biron, A Barbieux, P Bachmann.   

Abstract

Resting energy expenditure (REE) was measured by indirect calorimetry during allogeneic and autologous bone marrow transplantation in order to evaluate the evolution in allogeneic and autologous recipient patients. REE values obtained with indirect calorimetry and compared with values using the Harris-Benedict formula were different. Evolution of REE during aplasia were significantly different in autologous and allogeneic recipients with an increase 11.5 ' 10.8 cent for autologous and a decrease of - 7.3 ' 8.9 cent in allogeneic bone marrow transplantation (BMT) patients. There were no differences in nutritional status and REE before BMT, at discharge and 1 month after discharge between the two groups but all patients had inflicted damage on their nutritional status at discharge from hospital after BMT. However, these patients differed because of the decrease in oral nutritional intake and an increase in the length of aplasia and hospital stay in allogeneic patients. Currently, there is no proof that recommendations for nutritional interventions or results of nutritional investigations in allogeneic BMT can be extrapolated in autologous patients. Harris-Benedict formula does not estimate the energy expenditure of patients submitted to massive chemotherapy and BMT with enough precision because of the great differences in individuals.

Entities:  

Mesh:

Year:  1998        PMID: 10205347     DOI: 10.1016/s0261-5614(98)80316-6

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  5 in total

1.  Effect of titrated parenteral nutrition on body composition after allogeneic hematopoietic stem cell transplantation in children: a double-blind, randomized, multicenter trial.

Authors:  Tanvi S Sharma; Lori J Bechard; Henry A Feldman; Robert Venick; Kathleen Gura; Catherine M Gordon; Andrew Sonis; Eva C Guinan; Christopher Duggan
Journal:  Am J Clin Nutr       Date:  2011-12-28       Impact factor: 7.045

2.  Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: children and adolescents.

Authors:  Juliana Moura Nabarrete; Andrea Z Pereira; Adriana Garófolo; Adriana Seber; Angela Mandelli Venancio; Carlos Eduardo Setanni Grecco; Carmem Maria Sales Bonfim; Claudia Harumi Nakamura; Daieni Fernandes; Denise Johnsson Campos; Fernanda Luisa Ceragioli Oliveira; Flávia Krüger Cousseiro; Flávia Feijó Panico Rossi; Jocemara Gurmini; Karina Helena Canton Viani; Luciana Fernandes Guterres; Luiz Fernando Alves Lima Mantovani; Luiz Guilherme Darrigo Junior; Maria Isabel Brandão Pires E Albuquerque; Melina Brumatti; Mirella Aparecida Neves; Natália Duran; Neysimelia Costa Villela; Victor Gottardello Zecchin; Juliana Folloni Fernandes
Journal:  Einstein (Sao Paulo)       Date:  2021-12-10

3.  A multi-center, randomized, controlled trial of parenteral nutrition titrated to resting energy expenditure in children undergoing hematopoietic stem cell transplantation ("PNTREE"): rationale and design.

Authors:  Lori J Bechard; Henry A Feldman; Catherine Gordon; Kathleen Gura; Andrew Sonis; Kathryn Leung; Robert Venick; Eva C Guinan; Christopher Duggan
Journal:  Contemp Clin Trials       Date:  2010-01-03       Impact factor: 2.226

4.  Attenuation of resting energy expenditure following hematopoietic SCT in children.

Authors:  L J Bechard; H A Feldman; R Venick; K Gura; C Gordon; A Sonis; N Mehta; E C Guinan; C Duggan
Journal:  Bone Marrow Transplant       Date:  2012-02-20       Impact factor: 5.483

5.  Pretreatment hepatoprotective effect of the marine fungus derived from sponge on hepatic toxicity induced by heavy metals in rats.

Authors:  Nehad M Abdel-Monem; Ahmed M Abdel-Azeem; El-Sayed H El-Ashry; Doaa A Ghareeb; Asmaa Nabil-adam
Journal:  Biomed Res Int       Date:  2013-01-13       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.